A Head of Its Time: LED Sculpture Takes Larger-Than-Life Selfies

An interactive public art exhibit unveiled at the Greater Columbus (OH) Convention Center is taking the art of the selfie to a whole new level. Conceived by artist Matthew Mohr, As We Are is a 15-foot LED sculpture shaped in the likeness of a human head.

The one-of-a-kind installation, engineered and produced by Design Communications Ltd. (DCL), invites guests to step inside a photobooth where 32 cameras snap photos of a subject’s face. Facial recognition software then assembles the images into a flattened texture map which is then broadcast onto the exterior of the sculpture for all to see.

The art piece is “intended to present Columbus as a welcoming, diverse society,” says Mohr, who suggests that the exhibit offers a commentary on the role that social media plays in our culture.

“Something like this has never been done before,” says Jason Helton, executive vice president of SNA Displays. “We pride ourselves in our vast engineering capability, and we really excel in highly custom projects like the LED head sculpture.”

To read the original article, click here.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More